Reperfusion injury pathophysiology in sickle transgenic mice

Blood

Volumn 96, Issue 1, 2000, Pages 314-320

  Osarogiagbon, U Raymond ^a   Choong, Stephana ^a   Belcher, John D ^a   Vercellotti, Gregory M ^a   Paller, Mark S ^a   Hebbel, Robert P ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; ALLOPURINOL; ETHANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLIC ACID; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HYPOXIA; MOUSE; NONHUMAN; OXYGEN TENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

EID: 0034235705     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.314.013k39_314_320     Document Type: Article

References (58)

1. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159.
2. Southorn PA, Powis G. Free radicals in medicine, I & II. Mayo Clin Proc. 1988;63:381.
3. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci. 1994;307:284.
4. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47: 412.
5. Voogd A, Sluiter W, van Eijk HG, Koster JF. Low molecular weight iron and the oxygen paradox in isolated rat hearts. J Clin Invest. 1992;90:2050.
6. Kirschner RE, Fantini GA. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll of Surg. 1994;179:103.
7. Ramos CL, Pou S, Britigan BE, Cohen MS, Rosen GM. Spin trapping evidence for myeloper-oxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem. 1992;267:8307.
8. Gute DC, Ishida T, Yarimizu K, Korthuis RJ. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem. 1998; 179:169.
9. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995;57:311.
10. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med. 1998;25:404.
11. Humphries KM, Yoo Y, Szweda LI. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry. 1998;37:552.
12. Sen CK, Packer LP. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;10:709.
13. Helenius M, Hanninen M, Lehtinen SK, Salminen AJ. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol. 1996;28:487.
14. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 1995;9:899.
15. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066.
16. Oeth PA, Parry GC, Kunsch C, Nantermet P, Rosen CA, Machman N. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol Cell Biol. 1994;14:3772.
17. Embury SH, Hebbel RP, Steinberg MH, Mohandas N: Pathogenesis of vasoocclusion. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:311.
18. Faller DV. Vascular modulation. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:235.
19. s- and α-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A. 1992;89:12150.
20. s- and α-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A. 1992;89:12155.
21. Fabry M. Transgenic animal models. In Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994;105.
22. Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Rad Biol Med. 1994;17: 127.
23. Preece NE, Evans PF, King LJ, Parke DV. Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetate-induced lipid peroxidation in rats and mice. Xenobiotica. 1990;20:879.
24. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol. 1996;24:200.
25. Kawabata T, Ogino T, Awai M. Protective effects of glutathione against lipid peroxidation in chronically iron-loaded mice. Biochim Biophys Acta. 1989;1004:89.
26. Younes M, Siegers C-P. The role of iron in the paracetamol-and CCI4-induced lipid peroxidation and hepatotoxicity. Chem Biol Interact. 1985;55: 327.
27. +-supported in vivo lipid peroxidation induced by compounds undergoing redox cycling. Chem Biol Interact. 1985;54:97.
28. Lawrence GD, Cohen G. Ethane exhalation as an index of in vivo lipid peroxidation: concentrating ethane from a breath collection chamber. Analyt Biochem. 1982;122:283.
29. Massias L, Postaire E, Renault C, Hazebroucq G. Thermal desorption-gas chromatographic determination of ethane and pentane in breath as potential markers of lipid peroxidation. Biomed Chromatogr. 1993;7:200.
30. Coudray C, Talla M, Martin S, Fatome M, Favier A. High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as in vivo marker of oxidative stress. Analyt Biochem. 1995;227:101.
31. Halliwell B, Kaur H, Ingelman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Rad Biol Med. 1991;10:439.
32. Kim PH, Wells PG. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate formation. Mol Pharmacol. 1996;49: 172.
33. Hall ED, Andrus PK, Yonkers PA. Brain hydroxyl radical generation in acute experimental head injury. J Neurochem. 1993;60:588.
34. Althaus JS, Andrus PK, Williams CM, Von Voigtlander PF, Cazers AR, Hall ED. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Mol Chem Neuropathol. 1993;20:147.
35. Deryckere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 1994; 16:405.
36. Bierhaus A, Zhang Y, Deng Y, et al. Mechanism of the tumor necrosis factor α-mediated induction of endothelial tissue factor. J Biol Chem. 1995;270: 26419.
37. Bohrer H, Qiu F, Zimmerman T, et al. Role of NFκ B in the mortality of sepsis. J Clin Invest. 1997;100:972.
38. Backman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Rad Biol Med. 1989;6:607.
39. Siddiqi NJ, Pandey VC. Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice. Mol Cell Biochem. 1999; 196:169.
40. Srivastava M, Kale RK. Effect of radiation on the xanthine oxidoreductase system in the liver of mice. Rad Res. 1999;152:257.
41. Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood. 1991;77:214.
42. Nagel RL. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia. Semin Hematol. 1991;28:180.
43. Embury SE, Steinberg MH. Genetic modulators of disease. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:299.
44. Poillon WN, Kim BC, Castro O. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia. Blood. 1998;91:1777.
45. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course and mortality. Ann Intern Med. 1991;115:614.
46. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639.
47. Akinola NO, Stevens SME, Franklin IM, Nash GB, Stuart J. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992;45:902.
48. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499.
49. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. J Clin Invest. 1996;97:493.
50. Francis RB, Hebbel RP. Hemostasis. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994:299.
51. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1162.
52. Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest. 1998;101:1899.
53. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest. 1997;99: 2561.
54. Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med. 1997; 129:288.
55. Paller MS, Hebbel RP. Ethane production as a measure of lipid peroxidation after renal ischemia. Am J Pnysiol. 1986;251:F839.
56. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab. 1991;17:124.
57. Kaul DK, Hebbel RP. Leukocyte-endothelial interactions in transgenic sickle mice during steady-state and after hypoxia-reoxygenation [abstract]. Blood. 1999;94(suppl):676a.
58. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 1999;6:167.